Aug 12, 2026 04:07PM
Aug 10, 2026 02:42PM
Aug 5, 2026 11:58AM
Jul 17, 2026 04:17PM
Apr 21, 2026 06:35AM
Apr 17, 2026 08:31AM
Mar 31, 2026 08:14AM TD Cowen on Royalty Pharma (RPRX): BIIB Ph2 results 'de-risks upside potential for royalty'
Mar 30, 2026 07:16AM
Mar 23, 2026 07:15AM
Mar 17, 2026 04:02PM
Mar 2, 2026 06:01AM
Feb 27, 2026 01:43PM
Feb 12, 2026 05:52AM
Feb 11, 2026 04:57PM Royalty Pharma plc (RPRX) Reports Q4 results
Jan 30, 2026 04:16AM
Jan 12, 2026 07:15AM
Jan 12, 2026 04:07AM
Jan 12, 2026 04:04AM
Jan 9, 2026 08:32AM
Dec 29, 2025 04:42PM
Dec 22, 2025 04:16PM Royalty Pharma names McGivern as chief legal officer
Dec 16, 2025 07:15AM
Dec 11, 2025 10:12AM
Dec 4, 2025 07:02AM
Nov 6, 2025 04:13AM
Nov 4, 2025 07:15AM
Sep 30, 2025 05:07AM
Sep 29, 2025 08:16AM Royalty Pharma names Dr. Ted Love as lead independent director
Sep 16, 2025 09:42AM
Sep 12, 2025 09:16AM
Sep 3, 2025 05:44AM
Sep 2, 2025 07:15AM
Aug 25, 2025 06:01AM
Aug 13, 2025 04:15PM
Aug 6, 2025 12:23PM Royalty Pharma (RPRX) PT Raised to $48 at BofA Securities
Jul 22, 2025 05:02AM
Jul 18, 2025 08:15AM
Jul 17, 2025 08:15AM
Jun 24, 2025 07:06AM
May 16, 2025 06:12AM
May 12, 2025 04:17PM
May 12, 2025 04:15PM Royalty Pharma plc (RPRX) Announces Shareholder Approval of its External Manager Acquisition
Apr 8, 2025 04:15PM
Mar 27, 2025 09:24AM
Mar 27, 2025 08:29AM
Feb 12, 2025 06:30AM
Feb 11, 2025 07:54AM
Jan 29, 2025 09:04AM
Jan 14, 2025 02:22PM Royalty Pharma plc (RPRX) 2900 contracts of July 32.50 calls trade
Jan 10, 2025 07:16AM

446,800 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All